Medtronic plc (MDT) : Medtronic plc (MDT) had a healthy money flow of $24.13 million into the stock during the Fridays trading session. The value of bullish trades on upticks was $62.28 million, whereas, investors only sold shares worth $38.15 million on downticks. The stock closed the day with an up-down ratio of 1.63.The money flow in the block trades to the tune of $24.97 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $24.97 million worth of transactions were on upticks. Medtronic plc (MDT) stock slid $0.05 intraday and traded at 86.98, a change of -0.06% over previous days close. However, for the week, the company shares are 0.44% compared to previous weeks close.
The company Insiders own 0.25% of Medtronic plc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -13.61% . Institutional Investors own 82.98% of Medtronic plc shares. During last six month period, the net percent change held by insiders has seen a change of -8%.
In a related news, The Securities and Exchange Commission has divulged that Hanson Bryan C, officer (EVP, President, MITG) of Medtronic Plc, had unloaded 15,000 shares at an average price of $87 in a transaction dated on August 29, 2016. The total value of the transaction was worth $1,305,000.
Medtronic plc (NYSE:MDT): The stock opened at $87.22 and touched an intraday high of $87.86 on Friday. During the day, the stock corrected to an intraday low of $87.18, however, the bulls stepped in and pushed the price higher to close in the green at $87.32 with a gain of 0.39% for the day. The total traded volume for the day was 3,325,280. The stock had closed at $86.98 in the previous trading session.
Medtronic plc (MDT) : Traders are bullish on Medtronic plc (MDT) as it has outperformed the S&P 500 by a wide margin of 0.4% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 0.33%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.83% in the last 1 week, and is up 0.26% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.